Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

被引：1

作者：

Meguro, Masaki ^{[1
]}

Miyauchi, Satoru ^{[2
]}

Kanao-Arisumi, Yukiko ^{[3
]}

Naito, Satoru ^{[4
]}

Suzuki, Kanae ^{[1
]}

Inoue, Shinichi ^{[5
]}

Yamada, Keisuke ^{[6
]}

Homma, Tsuyoshi ^{[1
]}

Chiba, Kiyoshi ^{[1
]}

Nara, Futoshi ^{[7
]}

Furuzono, Shinji ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Technol Div, Technol Business Management Grp, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan

[3] Pharmaun Co Ltd, 1-23-39 Hiikawa,Jounan Ku, Fukuoka, Fukuoka 8140153, Japan

[4] Daiichi Sankyo Business Associe Co Ltd, Site Operat Dept, Shinagawa Site Operat Grp, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA

[6] Daiichi Sankyo Co Ltd, Med Affairs Div, Med Affairs Planning Dept, 3-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038426, Japan

[7] Shin Nippon Biomed Labs Ltd, 8-1-28 Akashicho,Chuo Ku, Tokyo 1040044, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 108卷

关键词：

Aldosterone; Aldosterone synthase inhibitor; Sulfone; Amino-pyrimidine; IN-VIVO ACTIVITY; POTENTIAL TREATMENTS; DISCOVERY; LCI699; THIOLS;

D O I：

10.1016/j.bmc.2024.117775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

引用

页数：15

共 50 条

[11] Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction
Hengstenberg, C
Holmer, SR
Mayer, B
Löwel, H
Engel, S
Hense, HW
Riegger, GAJ
Schunkert, H
HYPERTENSION, 2000, 35 (03) : 704 - 709
[12] Fluorinated aldosterone synthase (CYP11B2)-inhibitors for differential diagnosis between bilateral and unilateral conditions of primary aldosteronism
Maier, Philipp
Heinze, Britta
Gabor, Sabine
Reese, Samario
Hahner, Stefanie
Schirbel, Andreas
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 96
[13] Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3
Taymans, SE
Pack, S
Pak, E
Torpy, DJ
Zhuang, ZP
Stratakis, CA
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 1033 - 1036
[14] Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma
Yoshii, Yoko
Oki, Kenji
Gomez-Sanchez, Celso E.
Ohno, Haruya
Itcho, Kiyotaka
Kobuke, Kazuhiro
Yoneda, Masayasu
HYPERTENSION, 2016, 68 (06) : 1432 - 1437
[15] DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases
Takeda, Yoshimichi
Demura, Masashi
Yoneda, Takashi
Takeda, Yoshiyu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
[16] Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2
Davies, E
Holloway, CD
Ingram, MC
Inglis, GC
Friel, EC
Morrison, C
Anderson, NH
Fraser, R
Connell, JMC
HYPERTENSION, 1999, 33 (02) : 703 - 707
[17] The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation
Connell, JMC
Fraser, R
MacKenzie, SM
Friel, EC
Ingram, MC
Holloway, CD
Davies, E
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 217 (1-2) : 243 - 247
[18] Aldosterone synthase gene (CYP11B2) promoter polymorphism as a risk factor for ischaemic stroke in Tunisian Arabs
Saidi, Sarra
Mahjoub, Touhami
Almawi, Wassim Y.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (03) : 180 - 186
[19] Association between Aldosterone Synthase CYP11B2 Polymorphism and Essential Hypertension in Chinese: A Meta-Analysis
Cheng, Xiaoshu
Xu, Gaosi
KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (02) : 128 - 140
[20] Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11b-hydroxylase (CYP11B1) inhibitors.: Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension
Bureik, M
Hübel, K
Dragan, CA
Scher, J
Becker, H
Lenz, N
Bernhardt, R
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 217 (1-2) : 249 - 254

← 1 2 3 4 5 →